ZNTL
Zentalis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.30
+7.98%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$0.58
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.59
- EPS estimate
- -$0.49
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -10.5%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $11
- PT range
- $10 – $11
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.49 | -$0.59 | Miss -20.41% | — |
| May 12, 2026 | -$0.49 | -$0.50 | Miss -2.04% | — |
| Mar 26, 2026 | -$0.41 | -$0.49 | Miss -19.51% | — |
| May 14, 2025 | -$0.67 | -$0.67 | In line | — |
| Mar 26, 2025 | -$0.75 | -$0.66 | Beat 12.00% | $26.9M |
| Aug 9, 2024 | -$0.83 | -$1.24 | Miss -49.40% | — |
| Feb 27, 2024 | -$0.92 | -$0.83 | Beat 9.78% | $2.1M |
| Mar 1, 2023 | -$1.09 | -$0.92 | Beat 15.60% | — |
| May 5, 2022 | -$1.20 | -$1.31 | Miss -9.17% | — |
| Feb 24, 2022 | -$1.34 | -$1.11 | Beat 17.16% | — |
| Nov 10, 2021 | -$1.31 | -$0.09 | Beat 93.13% | — |
| Aug 12, 2021 | -$1.14 | -$1.34 | Miss -17.54% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026